Explore the top tutorials for learning how to draw body types—covering everything from anatomy and proportions to poses and ...

Dutch firm The Compound Company BV has reached an agreement for the sale of 100% of its shares to Industrie Polieco – M.P.B., a leader in production of piping systems and resins for coating and ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...

Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies The new class of GLP-1 medicines exemplifies both the ...

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, ...

The school, called BBS, enrolled 14 children in kindergarten through fourth grade and employed three full-time teachers and other staff members. By Heather Knight Reporting from the Crescent Park ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

Pharmacy compounding is one of the topics in the EU Pharma Law Package that has perhaps received less attention compared to topics such as regulatory exclusivity rights, shortages, and sustainability.

Please provide your email address to receive an email when new articles are posted on . Speakers at a congressional briefing highlighted safety concerns around counterfeit GLP-1 drugs. A white paper ...

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...